AI-assisted, human-published
10/02/2025 /Funding Events
Star Therapeutics Secures $125M in Series D Financing for Antibody Development
Star Therapeutics secures oversubscribed $125 million funding round co-led by Sanofi Ventures and Viking Global Investors to develop best-in-class antibodies for bleeding disorders and other diseases.
AI-assisted, human-published
Latest headlines
-
-
-
Stay connected!
If you have a serious, bonafide inquiry into the VentureCapital.com or PrivateEquity.com domain names, please contact us here
©2023 VentureCapital.com